10/9/24 13:18 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | P.a | 20 | 0.2900 | 0 | 69 | 54 | 197 | D | | | | | | | | | | | | | | |
10/8/24 10:42 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P.a | 20 | 0.2900 | 0 | 69 | 4 | 1,655 | D | | | | | | | | | | | | | | |
10/7/24 11:29 | 9/6/24 | NUTX | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P.a | 20 | 0.2900 | 0 | 69 | 4 | 1,655 | D | | | | | | | | | | | | | | |
10/4/24 19:40 | 10/2/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | P | 100 | 2.97 | 0 | 34 | New | 34 | D | | | | | | | | | | | | | | |
10/4/24 19:00 | 10/2/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 3,878 | 2.95 | 0 | 1,315 | 12 | 12,489 | M | | | | | | | | | | | | | | |
9/23/24 16:24 | 9/6/24 | NUTX | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | P.a | 20 | 0.2900 | 0 | 69 | 54 | 197 | D | | | | | | | | | | | | | | |
9/10/24 17:22 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Philibert Robert | IL | DO | Chief Me | P | 10 | 0.2865 | 0 | 34 | 2 | 1,684 | I | | | | | | | | | | | | | | |
9/9/24 11:08 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | O | CTO | P | 20 | 0.2900 | 0 | 69 | 54 | 197 | D | | | | | | | | | | | | | | |
9/9/24 11:01 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P | 20 | 0.2900 | 0 | 69 | 4 | 1,684 | D | | | | | | | | | | | | | | |
8/21/24 08:26 | 8/20/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 101 | 0.6700 | 0 | 150 | 6 | 2,781 | D | | | | | | | | | | | | | | |
8/7/24 10:17 | 8/6/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 51 | 16.86 | 0 | 3 | 15 | 23 | D | | | | | | | | | | | | | | |
7/16/24 21:13 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Telegraph Hill Partners Iv, L.P. | CA | T | | P | 15,000 | 1.24 | 0 | 12,097 | 83 | 26,591 | I | | | | | | | | | | | | | | |
7/16/24 17:15 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lowell Matthew | CA | O | CFO | P | 50 | 1.24 | 0 | 40 | 46 | 128 | D | | | | | | | | | | | | | | |
7/16/24 17:15 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | P | 100 | 1.24 | 0 | 81 | 50 | 243 | D | | | | | | | | | | | | | | |
7/11/24 17:15 | 7/9/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T | | P.d | 0 | 0.00 | 0 | 7 | 0 | 1,919 | D | | | | | | | | | | | | | | |
6/18/24 16:12 | 1/26/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T | | P.d | 0 | 0.00 | 0 | 29 | 2 | 1,912 | I | | | | | | | | | | | | | | |
6/3/24 17:30 | 5/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | CEO | P | 23 | 2.42 | 0 | 9 | 16 | 71 | D | | | | | | | | | | | | | | |
4/17/24 12:04 | 4/17/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 124 | 12.36 | 0 | 10 | 28 | 46 | D | | | | | | | | | | | | | | |
4/15/24 19:21 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 7,058 | 2.92 | 0 | 2,420 | 33 | 9,858 | M | | | | | | | | | | | | | | |
4/15/24 06:04 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Josh | CA | DO | CEO,P | P | 10 | 2.95 | 0 | 3 | 999% | 4 | D | | | | | | | | | | | | | | |
4/15/24 06:02 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | P | 100 | 2.95 | 0 | 34 | 67 | 85 | D | | | | | | | | | | | | | | |
4/11/24 11:40 | 4/11/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | DE | D | | P | 98 | 13.06 | 0 | 8 | 54 | 21 | D | | | | | | | | | | | | | | |
4/10/24 16:18 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 156 | 12.51 | 0 | 13 | 71 | 30 | D | | | | | | | | | | | | | | |
4/10/24 14:25 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 284 | 12.36 | 0 | 23 | 18 | 152 | D | | | | | | | | | | | | | | |
3/8/24 11:24 | 3/6/24 | CATX | Perspective Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lantheus Alpha Therapy, LLC | MA | T | | P | 57,409 | 0.9500 | 0 | 60,431 | 107 | 116,773 | D | | | | | | | | | | | | | | |
3/6/24 16:49 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | P.d | 46 | 4.59 | 0 | 10 | 35 | 39 | D | | | | | | | | | | | | | | |
3/6/24 16:43 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P.d | 46 | 4.59 | 0 | 10 | 15 | 77 | D | | | | | | | | | | | | | | |
2/27/24 16:21 | 8/15/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Grossman Paul David | CA | D | | P.m | 50 | 5.37 | 0 | 9 | New | 9 | D | | | | | | | | | | | | | | |
2/26/24 18:48 | 2/23/24 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Busky Joseph M | CA | O | CFO | P | 100 | 46.36 | 0 | 2 | 54 | 6 | I | | | | | | | | | | | | | | |
1/30/24 20:31 | 1/26/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P.d | 0 | 0.00 | 0 | 2 | 4 | 61 | D | | | | | | | | | | | | | | |
12/19/23 10:59 | 12/18/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.8300 | 0 | 10 | 4 | 278 | D | | | | | | | | | | | | | | |
12/18/23 09:38 | 12/15/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.7700 | 0 | 10 | 4 | 268 | D | | | | | | | | | | | | | | |
12/14/23 09:11 | 12/13/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | NV | O | Secretar | P | 6 | 0.6000 | 0 | 10 | 1 | 1,086 | D | | | | | | | | | | | | | | |
12/11/23 08:51 | 12/8/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 7 | 0.6700 | 0 | 10 | 0 | 2,746 | D | | | | | | | | | | | | | | |
12/6/23 17:21 | 12/6/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P | 17 | 3.36 | 0 | 5 | 9 | 59 | D | | | | | | | | | | | | | | |
12/1/23 17:44 | 11/30/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gelhaus Ken | CA | O | Chief Co | P | 6 | 1.73 | 0 | 4 | 19 | 23 | D | | | | | | | | | | | | | | |
11/28/23 09:39 | 11/27/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 15 | 0.7700 | 0 | 20 | 1 | 2,601 | D | | | | | | | | | | | | | | |
11/28/23 09:39 | 11/27/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Futcher Edward | NV | D | | P | 7 | 0.8000 | 0 | 9 | 2 | 428 | D | | | | | | | | | | | | | | |
11/27/23 10:28 | 11/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 8 | 0.7600 | 0 | 10 | 0 | 2,581 | D | | | | | | | | | | | | | | |
11/24/23 11:06 | 11/22/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 14 | 0.7100 | 0 | 20 | 1 | 2,571 | D | | | | | | | | | | | | | | |
11/17/23 10:01 | 11/16/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.8100 | 0 | 10 | 4 | 258 | D | | | | | | | | | | | | | | |
11/3/23 13:59 | 11/3/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | P | 32 | 16.06 | 0 | 2 | 8 | 27 | D | | | | | | | | | | | | | | |
10/26/23 08:01 | 10/25/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 152 | 15.17 | 0 | 10 | 38 | 36 | D | | | | | | | | | | | | | | |
10/12/23 16:01 | 10/12/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 46 | 15.19 | 0 | 3 | 17 | 20 | D | | | | | | | | | | | | | | |
10/11/23 16:21 | 10/11/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 150 | 15.03 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
9/21/23 20:58 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Telegraph Hill Partners Iv, L.P. | CA | T | | P | 15,000 | 1.85 | 0 | 8,108 | 46 | 25,621 | M | | | | | | | | | | | | | | |
9/21/23 17:04 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrill Damon | CA | O | GC,CCO | P | 50 | 1.85 | 0 | 27 | 193 | 41 | D | | | | | | | | | | | | | | |
9/21/23 17:04 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mackowski J Matthew | CA | D | | P | 1,500 | 1.85 | 0 | 811 | 999% | 821 | I | | | | | | | | | | | | | | |
9/21/23 17:03 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lowell Matthew | CA | O | CFO | P | 100 | 1.85 | 0 | 54 | 159 | 88 | D | | | | | | | | | | | | | | |
9/21/23 17:03 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | P | 100 | 1.85 | 0 | 54 | 50 | 163 | D | | | | | | | | | | | | | | |
9/19/23 16:05 | 8/31/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Henshall Mickie | NV | D | | P | 5 | 1.25 | 0 | 4 | 25 | 19 | D | | | | | | | | | | | | | | |
9/12/23 18:37 | 9/8/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hombeck Torsten | TX | O | CFO | P | 10 | 4.30 | 0 | 2 | 298 | 3 | D | | | | | | | | | | | | | | |
9/8/23 12:18 | 8/25/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DOT | CEO | P.m | 10 | 0.5460 | 0 | 18 | 17 | 128 | I | | | | | | | | | | | | | | |
9/8/23 12:12 | 8/25/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | P.m | 10 | 0.5460 | 0 | 18 | 17 | 128 | D | | | | | | | | | | | | | | |
9/6/23 10:01 | 9/5/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Barnes Phillip | NV | D | | P | 7 | 1.30 | 0 | 5 | 25 | 25 | D | | | | | | | | | | | | | | |
9/5/23 16:14 | 8/24/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Philibert Robert | IL | DOT | Chief Me | P.m | 20 | 0.5999 | 0 | 34 | 1 | 3,282 | I | | | | | | | | | | | | | | |
9/1/23 09:41 | 8/31/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | NV | D | | P | 12 | 1.28 | 0 | 10 | 0 | 2,030 | D | | | | | | | | | | | | | | |
8/31/23 09:35 | 8/29/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P.m | 25 | 1.25 | 0 | 20 | 6 | 328 | I | | | | | | | | | | | | | | |
8/28/23 10:07 | 8/25/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P | 25 | 1.24 | 0 | 20 | 7 | 308 | D | | | | | | | | | | | | | | |
8/25/23 11:49 | 8/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Kway Jasmine | NV | O | CEO - Si | P | 6 | 1.20 | 0 | 5 | 6 | 87 | I | | | | | | | | | | | | | | |
8/25/23 11:49 | 8/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Futcher Edward | NV | D | | P | 6 | 1.22 | 0 | 5 | 1 | 419 | D | | | | | | | | | | | | | | |
8/24/23 17:58 | 8/24/23 | MYMD | Mymd Pharmaceuticals, Inc. | NJ | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivard Paul | MD | O | GC | P | 167 | 1.11 | 0 | 150 | 60 | 400 | D | | | | | | | | | | | | | | |
8/24/23 12:00 | 8/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Michel Gaetan | NV | O | COO | P | 6 | 1.23 | 0 | 5 | 2 | 213 | D | | | | | | | | | | | | | | |
8/18/23 16:21 | 8/17/23 | MYMD | Mymd Pharmaceuticals, Inc. | NJ | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivard Paul | MD | O | GC | P | 28 | 1.12 | 0 | 25 | 11 | 250 | D | | | | | | | | | | | | | | |
8/17/23 09:40 | 8/16/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 10 | 1.21 | 0 | 8 | 3 | 254 | D | | | | | | | | | | | | | | |
8/16/23 12:28 | 8/16/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 12 | 1.22 | 0 | 10 | 0 | 2,536 | D | | | | | | | | | | | | | | |
7/26/23 19:28 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fralick Celeste Rachelle | TX | D | | P | 3 | 3.98 | 0 | 1 | 7 | 12 | D | | | | | | | | | | | | | | |
7/26/23 16:28 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vos Ellen O'Connor | CT | D | | P | 15 | 3.98 | 0 | 4 | 13 | 33 | D | | | | | | | | | | | | | | |
7/25/23 17:39 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T | | P | 500 | 2.75 | 0 | 182 | 11 | 1,884 | I | | | | | | | | | | | | | | |
7/25/23 17:20 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cavanaugh Stefanie L. | TX | D | | P | 25 | 3.98 | 0 | 6 | 22 | 35 | D | | | | | | | | | | | | | | |
7/25/23 17:16 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P | 50 | 3.98 | 0 | 13 | 10 | 135 | D | | | | | | | | | | | | | | |
7/25/23 17:11 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Phan Ryan Thinh | TX | O | CSO,COO | P | 2 | 3.98 | 0 | 1 | 19 | 4 | D | | | | | | | | | | | | | | |
7/25/23 17:03 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Parnell Winfred | TX | D | | P | 25 | 3.98 | 0 | 6 | 25 | 32 | D | | | | | | | | | | | | | | |
7/25/23 16:58 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Merchant Minh Hoang | TX | O | GC,secre | P | 3 | 3.98 | 0 | 1 | 18 | 5 | M | | | | | | | | | | | | | | |
7/24/23 18:58 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jordan Veronica Gh | TX | D | | P | 15 | 3.98 | 0 | 4 | 12 | 35 | D | | | | | | | | | | | | | | |
7/24/23 18:53 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hombeck Torsten | TX | O | CFO | P | 3 | 3.98 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
7/24/23 18:49 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Herchuk Jannie Prestridge | TX | D | | P | 35 | 3.98 | 0 | 9 | 58 | 24 | D | | | | | | | | | | | | | | |
6/26/23 10:27 | 4/25/23 | NYMX | Nymox Pharmaceutical Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Robinson James George | MD | DT | | P.am | 37 | 0.4600 | 0 | 80 | 2 | 4,782 | D | | | | | | | | | | | | | | |
6/15/23 20:13 | 6/14/23 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Alfred D | NY | D | | P | 6 | 0.2149 | 0 | 30 | 6 | 563 | D | | | | | | | | | | | | | | |
6/6/23 10:14 | 6/2/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 16 | 1.59 | 0 | 10 | 5 | 217 | D | | | | | | | | | | | | | | |
6/1/23 17:42 | 5/30/23 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P | 28 | 5.50 | 0 | 5 | 8 | 67 | D | | | | | | | | | | | | | | |
5/31/23 17:16 | 5/26/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Davis Ted | CA | DT | | P | 6 | 3.22 | 0 | 2 | 0 | 3,576 | D | | | | | | | | | | | | | | |
5/31/23 17:16 | 5/26/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Davis Irene | CA | DT | | P | 6 | 3.22 | 0 | 2 | 0 | 3,576 | I | | | | | | | | | | | | | | |
5/26/23 12:23 | 5/24/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P.m | 1 | 1.59 | 0 | 1 | 0 | 1,021 | D | | | | | | | | | | | | | | |